Trial intelligence / Profile preview

Hydrocortisone to reduce dexamethasone-related side effects in pediatric ALL

2011-003815-46Phase 3Completed

Sponsor
Erasmus MC
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute lymphoblastic leukemia (ALL) comparing Hydrocortisone arm with Placebo arm (2 arms). Primary endpoint: Parent-reported Strengths and Difficulties Questionnaire (Dutch version, SDQ-Dut). Started May 2012; status: completed.

02

Drugs

hydrocortisone
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on 2011-003815-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003815-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call